News
Where Will Growth Stocks Find a Bottom?
If you're a growth stock investor, the past few months have likely been a somewhat painful time. Just when you think your favorite stocks can't get beaten down any further, that's exactly what
Does Capital One's Discount to Peers Make the Stock a Value Play?
Capital One, the bank holding company that specializes in credit cards, has been grouped among those stocks that seem to have benefited nicely from the pandemic. As a result, its stock price is up
3 Top e-Commerce Stocks To Buy Right Now
There were many changes brought about by the pandemic, but the acceleration of e-commerce has been a big one and is likely to be a lasting one.
Studies are suggesting that many people who started
3 Growth Stocks Down 30% to 62% That Are Too Cheap to Ignore
Growth stocks have been battered over the last year of trading. While volatility may continue to shake the market in the near term, investors now have a sizable collection of great companies trading
Here's How Healthcare Stocks Have Historically Performed After a Down January
January was a bad month for the stock market. The S&P 500 declined by 5.3% and is coming off its worst month since March 2020 when the pandemic first started. Healthcare stocks fared even worse
Microsoft Acquisition the "Best Thing to Ever Happen to Activision Blizzard"
In mid-January, Microsoft (NASDAQ: MSFT) announced its plans to acquire troubled video game company Activision Blizzard (NASDAQ: ATVI) in a blockbuster $68.7 billion deal. In this episode of "The
Bitcoin vs. the S&P 500: Which Is the Better First Investment?
One of the first problems new investors run into is where they should invest. With thousands of publicly traded companies, there's no shortage of companies to choose from, and with the emergence of
1 Red Flag and 1 Green Flag for Scotts Miracle-Gro
Scotts Miracle-Gro (NYSE: SMG) has had a hard 12 months, with its shares down more than $100 from a year ago.
The gardening supply company with a connection to the cannabis market released its
3 Disruptive Stocks We Love This Valentine's Day
It's only February, but many investors might feel like they've seen enough volatility for an entire year. The tech-centric Nasdaq 100 index is down 11% year to date, with many individual technology
Does Roblox Have a Plan to Win the Metaverse?
The metaverse. It's hard to go five minutes in the world of investing without hearing about it. In fact, just about any company that can claim any stake in this new virtual world is doing so, or at
Crypto Is Recovering. Is It Time to Invest?
The cryptocurrency market has been shakier than usual over the past couple of months.
Late last year, many cryptos were reaching record highs. Since then, though, prices have been steadily
1 Beaten-Down SPAC IPO With Massive Long-Term Potential
The past few months haven't been kind to companies that went public via SPAC, but there are some excellent opportunities in this group that patient long-term investors might want to take a look at
3 Retirement Accounts That Run Circles Around a 401(k)
If you work for a company that offers a 401(k), you may be inclined to sign up. And if you're offered an employer match, it definitely pays to put enough money into that plan to claim that free
Consumer Spending Is Surging at Disney's Theme Parks
Disney (NYSE: DIS) reported fiscal 2022 first-quarter operating results after the market closed on Thursday, Feb. 9. The figures show a consumer eager to return to the magic at Disney's theme parks
What to Expect From Biogen's $2.3 Billion Shopping Spree
After selling its stake in a biosimilar joint venture with Samsung Biologics, Biogen (NASDAQ: BIIB) has reportedly now brought Goldman Sachs on board to identify potential acquisition targets. In
Market Crash 2022 -- Will Russia Invade Ukraine?
The stock market is crashing again off of reports that Russia could soon take military action against Ukraine. Additionally, inflation and interest rates already have investors on edge, and many
Here Are 2 Monster Stocks in the Making
The marijuana industry has been on a roller coaster ride since 2020. The pandemic sure did boost marijuana sales. The ramp-up of U.S. state legalization further uplifted the performance of cannabis
Want to Get Richer? 2 Stocks to Buy Now and Hold Forever
If you want to get richer over the next decade or longer, the best strategy is to simply start investing. From 1927 to 2018, the chances of making money were heavily stacked in the long-term
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
If omicron remains the dominant coronavirus strain, it's possible that omicron-specific versions of vaccines could enjoy greater future demand compared to rival vaccines that don't specifically
Should You Buy Alphabet Now or Wait Until After the Stock Split?
There's no denying that Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) has become a force to be reckoned with. Not many companies can boast that their signature product or service has become a verb
3 Drastic Moves That Could Save Your Retirement If You're Running Out of Cash
Running short of retirement savings can be really frightening for seniors. While Social Security benefits are guaranteed for life, they aren't enough to live on. This means older Americans will find
1 Key Metric Shows How Wells Fargo Can Recover
One key metric for evaluating bank stocks is the efficiency ratio, which measures a bank's total expenses expressed as a percentage of its total revenue. For example, if a bank has a 60% efficiency
Why AMD and Nvidia Were Down on Friday
Nvidia (NASDAQ: NVDA) is expected to report a strong quarter during its earnings call on Feb. 16, after Advanced Micro Devices (NASDAQ: AMD) crushed its recent earnings. Today's video focuses on the
Is the FDA's Partial Hold Bad News for Gilead Investors?
With Gilead Sciences' (NASDAQ: GILD) drug magrolimab now under a partial clinical hold with the U.S. Food and Drug Administration, how big of a setback could it be for the company? In this segment
5 Struggling Stocks to Buy at a Discount
The year was off to a rocky start for many top stocks. I'm talking about companies with attributes that could equal future performance -- such as solid revenue or profit growth, market leadership